| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC12012 | PD 404182 Featured | PD 404182 is a high affinity inhibitor of KDO 8-P synthase (Ki = 26 nM). Also inhibits dimethylarginine dimethylaminohydrolase 1 (DDAH1). Exhibits antiangiogenic and antiviral activity in vitro. Putative antibiotic against gram-negative bacteria. |
|
| DC10513 | AFN-1252(Debio 1452) Featured | AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ≤0.12 μg/ml. |
|
| DC9827 | AN3365(Epetraborole) Featured | AN3365 is a first-in-class antibiotic that demonstrates potent activity across a wide spectrum of Gram-negative bacteria, including those resistant to many other antibiotics. |
|
| DCAPI1362 | Azithromycin (Zithromax) | Azithromycin (Zithromax) |
|
| DC8809 | Bedaquiline fumarate Featured | Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis. |
|
| DC4143 | Besifloxacin HCl Featured | Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic. |
|
| DCAPI1024 | Cefditoren pivoxil | Cefditoren pivoxil |
|
| DC8937 | Clarithromycin | Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor. |
|
| DC10612 | Delpazolid (LCB01-0371) Featured | Delpazolid (LCB01-0371) is a new oxazolidinone with cyclic amidrazone. |
|
| DC1057 | Fidaxomicin (Dificid) Featured | Fidaxomicin, is an antibiotic that belongs to the class of macrocylic antibiotics. |
|
| DC10307 | Framycetin | Framycetin (Fradiomycin B; Neomycin B) is an aminoglycoside antibiotic. It inhibits hammerhead ribozyme with a Ki of 13.5 μM. |
|
| DC8929 | Garenoxacin | Garenoxacin is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections. |
|
| DC8893 | Garenoxacin Mesylate hydrate | Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains. |
|
| DC10161 | Gepotidacin Featured | Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor. |
|
| DC8928 | Minocycline hydrochloride Featured | Minocycline is a tetracycline antibiotic with neuroprotective, antiapoptotic, anti-inflammatory and antimicrobial effects. |
|
| DC4226 | Moxifloxacin hydrochloride Featured | Moxifloxacin(Avelox, Avalox) is a fourth generation synthetic fluoroquinolone antibacterial agent. |
|
| DC11273 | Murepavadin (POL7080) Featured | Murepavadin is a novel class of highly specific outer membrane protein targeting antibiotic to treat resistant Pseudomonas infections. |
|
| DC9723 | PBTZ169 Featured | PBTZ169 is a decaprenyl-phosphoribose-epimerase (DprE1) inhibitor. |
|
| DC10441 | Relebactam Featured | Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases [ESBLs] and KPC) and class C (AmpC) enzymes. |
|
| DC4148 | Retapamulin | Retapamulin is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM. |
|
| DCAPI1325 | Rifabutin (Mycobutin) | Rifabutin (Mycobutin) |
|
| DC8032 | Solithromycin Featured | Solithromycin is a novel ketolide antibiotic. |
|
| DC10733 | Sutezolid (PNU-100480) Featured | Sutezolid (PNU-100480) is an oxazolidinone antimicrobial being developed for the treatment of tuberculosis. |
|
| DC7940 | TBA-354 | TBA-354 is a potent anti-tuberculosis compound; maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and clinical drug-sensitive and drug-resistant isolates. |
|
| DC10286 | Vaborbactam Featured | Vaborbactam is a cyclic boronic acid pharmacophore β-lactamase inhibitor. |
|
| DC8115 | Vancomycin hydrochloride Featured | Vancomycin hydrochloride in stock,price: 500 USD/100mg. 0 |
|
| DC11277 | Zoliflodacin(AZD0914) Featured | Zoliflodacin (ETX0914;AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor. |
|
| DC10109 | Q203 Featured | Q203 is a promising new clinical candidate for the treatment of tuberculosis. |
|
| DC27000 | SPR741 (NAB741) Featured | SPR741 (NAB741) is a cationic peptide derived from polymyxin B and is a potentiator molecule. SPR741 increases the permeability of the outer membrane of Gram-negative bacteria and is used to treat severe Gram-negative bacteria infections. SPR741 inhibits |
|
